<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EF92F603-AE36-4BBF-9142-DDC959FAB29F"><gtr:id>EF92F603-AE36-4BBF-9142-DDC959FAB29F</gtr:id><gtr:firstName>Barbara</gtr:firstName><gtr:otherNames>Maria</gtr:otherNames><gtr:surname>Mcgowan</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6559"><gtr:id>0327FDD9-21E1-46DD-B5E3-AB246D9197F8</gtr:id><gtr:title>Role of insulin in the hypothalamic regulation of energy balance</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6559</gtr:grantReference><gtr:abstractText>The main systems regulating appetite and energy balance are located in a part of the brain called the hypothalamus. The exact mechanisms are not understood; therefore we need to unravel the roles of the various systems involved.

My project will examine a hormone of key importance in the regulation of appetite and energy balance, namely insulin. Chronic peripheral injections of insulin in diabetics cause weight gain, whereas chronic injections of insulin in rodent brains lead to weight loss. However, my own pilot data shows that chronic injections of insulin in a specific nucleus of the hypothalamus in rodents cause weight gain. My project will examine actions of insulin on different hypothalamic nuclei to address this conundrum.

I will produce animal models using gene therapy that will allow long-term changes in insulin signalling in the hypothalamus. In these animals I will measure energy expenditure by a number of different techniques. 

Obesity is arguably the biggest current threat to the health of mankind, and is now a major cause of premature death in the UK. Unravelling the mechanisms by which insulin exerts its hypothalamic actions on energy balance may lead to novel approaches to treating obesity.</gtr:abstractText><gtr:technicalSummary>1) 1) Insulin is a major metabolic hormone and the first adiposity signal to be described. Intracerebroventricular (ICV) injections of insulin in baboons and rodents potently reduce body weight and food intake. Knock-out mice with neuron-specific deletion of the insulin receptor become obese, but without affecting food intake. Although diabetics given insulin therapy gain weight, this was thought to be secondary to a decrease in glycosuria and improvements in general health.
2) 2) Preliminary results from my recent work exploring hypothalamic effects of insulin on energy balance have given rise to an apparent conundrum. The paraventricular nucleus (PVN) is a key area in the hypothalamic regulation of food intake and energy balance. I have chronically expressed insulin in the PVN by using recombinant adeno-associated virus (rAAV) encoding preproinsulin. Unlike chronic ICV insulin, chronic expression of insulin in the PVN caused a significant increase in body weight in adult rats. There was no statistically significant difference in food intake between the two groups. This suggests the novel concept that the influence of circulating insulin on energy balance may depend on its site of action within the hypothalamus.
3) 3) To investigate this, I will study the hypothalamic actions of insulin on energy balance by injecting rAAV encoding preproinsulin (rAAV-Ins) into the arcuate nucleus (ARC) and PVN. I will also reduce insulin signalling in these areas by preparing and injecting rAAV encoding protein tyrosine phosphatase 1B (rAAV-PTP1B) which terminates insulin signalling, or antisense cRNA to the insulin receptor (rAAV-aIR).
4) In all experimental animals I will investigate energy balance by examining: (a) whole body calorimetry (b) capacity of the brown adipose tissue (BAT) to expend energy (c) level of physical activity and (d) food intake. Three months after injection of rAAV I will investigate the body composition, hormones affecting energy balance such as thyroid, pituitary hormones and leptin, as well as uncoupling protein-1 (UCP-1) mRNA and protein levels in BAT. The effects of high fat diet will be examined on the above parameters.
5) Obesity has now reached pandemic proportions and is a major cause of premature death in the UK. Unravelling the insulin conundrum will help us to better understand the hypothalamic mechanisms by which insulin controls energy balance, and may lead to novel approaches to treating obesity.</gtr:technicalSummary><gtr:fund><gtr:end>2008-05-17</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-11-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>172774</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>house of commons</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>BE19FC2A-FA76-4C5C-A0EB-6E73EAE9B3DD</gtr:id><gtr:impact>Poster presentation at the house of commons

n/a</gtr:impact><gtr:outcomeId>6C58603BC61</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>97378918-397F-4532-8E0C-BE31EC349F2E</gtr:id><gtr:title>Low-dose pancreatic polypeptide inhibits food intake in man.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41ef34c6dbfc3fcd48d7fd69c1c75679"><gtr:id>41ef34c6dbfc3fcd48d7fd69c1c75679</gtr:id><gtr:otherNames>Jesudason DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>7CDC65884CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E279AE0B-42F1-4E35-ADD3-F352AC14CE53</gtr:id><gtr:title>Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats.</gtr:title><gtr:parentPublicationTitle>Regulatory peptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69ac71aa010bea0adc6be6d0e11cd6b9"><gtr:id>69ac71aa010bea0adc6be6d0e11cd6b9</gtr:id><gtr:otherNames>McGowan BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0167-0115</gtr:issn><gtr:outcomeId>DE16FD76B8F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23C663DD-CCEA-40FD-BC35-342B66009D6F</gtr:id><gtr:title>Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69ac71aa010bea0adc6be6d0e11cd6b9"><gtr:id>69ac71aa010bea0adc6be6d0e11cd6b9</gtr:id><gtr:otherNames>McGowan BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>0DEFB270069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E33C701E-9A52-457F-B958-E6275672A141</gtr:id><gtr:title>Relaxin-3 and its role in neuroendocrine function.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69ac71aa010bea0adc6be6d0e11cd6b9"><gtr:id>69ac71aa010bea0adc6be6d0e11cd6b9</gtr:id><gtr:otherNames>McGowan BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>B5320CB9831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D282B1B-B4E0-476A-8C58-36525964DFF4</gtr:id><gtr:title>Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69ac71aa010bea0adc6be6d0e11cd6b9"><gtr:id>69ac71aa010bea0adc6be6d0e11cd6b9</gtr:id><gtr:otherNames>McGowan BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>2E4E5ABA5DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E29DEDEB-0255-4ED5-A87D-B6497D2A478C</gtr:id><gtr:title>No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0af12ebfee15d84cb1a8ec5015afb61a"><gtr:id>0af12ebfee15d84cb1a8ec5015afb61a</gtr:id><gtr:otherNames>Neary NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>1D4FC79DF10</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6559</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>